Precision AQ’s Post

View organization page for Precision AQ, graphic
Precision AQ

22,748 followers

Even as a therapy enters the “late lifecycle,” medical affairs teams can’t slow down. Continuing to empower access to medicine years after launch can look like: ⚫ Continued evidence generation ⚫ Demonstrating the value against generic competition ⚫ Exploring broader use applications Ross Maclean, Head of Medical Affairs, and Uchenna Iloeje, MD share why and how med affairs teams can drive “safe and appropriate use” activities forward in a feature for Healthcare Business Today: https://lnkd.in/ei5Dhmgn #pharmaindustry #marketaccess #biopharma

  • No alternative text description for this image

To view or add a comment, sign in

More Relevant Posts

Precision AQ

22,748 followers

View Profile

Explore topics